Data Summary {#s2}
============

All fastq files and assemblies were submitted to the National Centre for Biotechnology Information (NCBI). All data can be found under BioProject: PRJNA248792, PRJNA248064 <https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA315192>. Strain-specific details can be found in Table S1.

###### Impact Statement

In this study we present the results of screening for *mcr* variants against Public Health England's considerable set of *[Salmonella](http://doi.org/10.1601/nm.3291)* genomes collected via routine national surveillance of gastrointestinal disease over a 4-year period, thereby elucidating the presence of *mcr*-containing *[Salmonella](http://doi.org/10.1601/nm.3291)* entering the food chain. Employing combined Illumina and Nanopore sequencing, we identified three novel *mcr-3* plasmids and one novel *mcr-5* plasmid, as well as the presence of chromosomally integrated *mcr-1* and *mcr-3*. This study highlights how routine whole-genome sequencing for public health surveillance provides an effective screen for novel and emerging antimicrobial determinants.

Introduction {#s3}
============

Colistin has been utilized as an antimicrobial last resort against Gram-negative bacteria exhibiting pan-resistance to multiple antimicrobials \[[@R1]\]. Colistin resistance has historically been attributed to intrinsic resistance or chromosomal mutations that are not transmissible within the population; however, the acquisition of mobile colistin resistance (*mcr*) genes borne on plasmids has recently been described \[[@R2]\]. Since 2015, eight variants of plasmid-mediated *mcr* genes have been detected in Gram-negative bacteria, including *[Salmonella enterica](http://doi.org/10.1601/nm.11017)*, *[Escherichia coli](http://doi.org/10.1601/nm.3093)*, *[Moraxella](http://doi.org/10.1601/nm.2746)* spp. and *[Klebsiella pneumoniae](http://doi.org/10.1601/nm.10789)* isolated from clinical human cases as well as pigs, calves, poultry, food and environmental sources \[[@R3]\]

The variety of *mcr* genes reported is mirrored in the variability of their genetic context. For *mcr-1*, at least 12 different plasmid replicons have been described, namely: IncX3, IncX4, an IncX3-X4 hybrid, IncH1, IncHI1, IncHI2, IncP, IncI2, IncF, IncFII, an IncI2--IncFIB hybrid and IncY \[[@R3]\]. *mcr-2* has been associated with an IncX4 plasmid \[[@R8]\], *mcr-3* has been found on a IncHI2, IncP and an IncR plasmid type \[[@R9]\], and both *mcr-4* and *mcr-5* have been described on a ColE-like plasmid \[[@R5]\]. *mcr-6* has been isolated integrated into the chromosome and *mcr-7* and *mcr-8* have been reported on an IncI2 and IncFII plasmid, respectively \[[@R4]\]. Recently, *mcr-9* was described in a *[Salmonella](http://doi.org/10.1601/nm.3291)* Typhimurium isolated in 2010 from a human patient in the USA \[[@R15]\].

Whole-genome sequencing (WGS) of bacterial isolates facilitates the detection of known resistance genes and resistance-associated mutations. The adoption of WGS for routine pathogen surveillance has consequently improved antimicrobial resistance (AMR) surveillance by enabling earlier detection of resistant strains \[[@R16]\] and by providing a framework for passive AMR surveillance. In 2016, a retrospective study to understand the prevalence of *mcr-1* in England identified 15 *mcr-1*-positive isolates within a large collection of genomes obtained from the surveillance of Gram-negative pathogens by Public Health England \[[@R17]\].

The aim of this study was to further investigate the prevalence of *mcr-1* to *-8* in *[S. enterica](http://doi.org/10.1601/nm.11017)* isolates submitted to Public Health England (PHE) through routine surveillance, to characterize the genomic context of *mcr* and to provide an insight into the dissemination of *mcr*-mediated colistin resistance in England from 2012 to September 2017.

Methods {#s4}
=======

WGS isolates {#s4-1}
------------

Since April 2014, WGS analysis has been performed routinely for the identification and typing of presumptive *[S. enterica](http://doi.org/10.1601/nm.11017)* isolates at PHE. Data obtained from WGS have been deposited and archived in the National Center for Biotechnology Information (NCBI) Sequence Read Archive -- BioProject: PRJNA248064. From April 2014 to September 2017, 31 292 *[Salmonella](http://doi.org/10.1601/nm.3291)* isolates were referred; 27 611 were isolated from human faeces, 1469 were isolated from human blood isolates, 335 were isolated from human urine, 171 were isolated from other human sites, 769 were isolated from non-human sources (environmental, animal and unspecified samples) and 937 were isolated from food. Additionally, the database also consisted of 1913 genome sequences obtained from clinical isolates from 2012 to 2013, making up 5 % of the collection. For clinical isolates, information concerning the age, sex and recent foreign travel of patients was obtained from the isolate referral form.

Sample preparation {#s4-2}
------------------

Genomic DNA purification was performed in accordance with the manufacturer's procedures using the Qiasymphony DSP DNA Midi kit (Qiagen, Hilden, Germany), while DNA extraction was performed using a Qiasymphony SP (Qiagen, Hilden, Germany) with DNA eluted with nuclease-free water. DNA concentration and quality was measured using a GloMax (Promega, WI, USA) and LabChip DX (Perkin Elmer, MA, USA), respectively. The sequencing DNA libraries of each sample were prepared using a Nextera XT DNA Library Prep kit (Illumina, CA, USA). Paired-end sequencing was achieved using a HiSeq 2500 instrument that produced 2×101 base pair (bp) reads. The reads were quality-trimmed using Trimmomatic v0.36 \[[@R18]\].

Multi-locus sequence typing (MLST) analysis was performed to identify genetically related isolates by sequence type (ST) using MOST \[[@R19]\]. Related STs were then designated into clonal complexes collectively termed eburst groups (eBGs) \[[@R20]\].

Screening for *mcr* variants {#s4-3}
----------------------------

The reference fasta sequences of the *mcr* genes were obtained from GenBank with the accession numbers KP347127, LT598652, KY924928, MF543359, KY807921, MF176240, MG267386 and MG736312 for *mcr-1*, *mcr-2*, *mcr-3*, *mcr-4*, *mcr-5*, *mcr-6*, *mcr-7* and *mcr-8*, respectively. The WGS paired-end reads of each sample were then scanned for the presence of *mcr-1* to *-8* variants using GeneFinder (<https://github.com/phe-bioinformatics/gene_finder>), a tool that incorporates Bowtie 2 v2.2.3 \[[@R21]\] and SAMtools v0.1.19 \[[@R22]\]. Positive hits were defined as those with nucleotide identity greater than or equal to 90 % over the length of the reference gene. Genomes that were positive for one or more *mcr* genes were further scanned against a reference database for AMR determinants available in the GeneFinder hitub repository using the same criteria as above (<https://github.com/phe-bioinformatics/gene_finder/tree/master/refs>).

Assembly and annotation {#s4-4}
-----------------------

Genomes were assembled using SPades v3.8.0 \[[@R23]\] with the options '\--only-assembler' and '-k 21, 33, 55, 77'. Quast v4.5 \[[@R24]\] was used with default settings to check the contiguity of assembled reads before visualizing the assembly graph with Bandage v0.8.1 \[[@R25]\]. Prokka v1.12 \[[@R26]\] was used with the options '\--kingdom Bacteria' to annotate putative contigs of significance identified in Bandage, before being deposited into Artemis v16.0.0 \[[@R27]\] to be viewed interactively for any notable coding sequences flanking the *mcr* gene.

Screening for plasmids {#s4-5}
----------------------

PlasmidFinder v1.3 \[[@R28]\] was used to identify known replicons that could be present within the queried genome. blastn was used to align the *mcr*-containing contig to a representative plasmid of that replicon type. Once a plausible comparator plasmid was identified, Mauve v2.4.0 \[[@R29]\] was used to position the contigs of the query sequence to their aligned location on the reference plasmid. Genomes associated with the same putative plasmid type were then grouped and viewed using [blast]{.smallcaps} Ring Image Generator (brig) v0.95 \[[@R30]\] and the genetic context of the *mcr* gene was analysed using Easyfig \[[@R31]\].

Phylogenetic analysis of *mcr*-positive genomes {#s4-6}
-----------------------------------------------

To explore the evolutionary relationships between isolates harbouring *mcr* genes, phylogenetic analysis was performed on the most common *mcr*-positive isolated *[Salmonella](http://doi.org/10.1601/nm.3291)* serotype, *[Salmonella](http://doi.org/10.1601/nm.3291)* Typhimurium. Illumina fastq reads from *mcr-*positive isolates belonging to eBG1 were mapped to the *[Salmonella](http://doi.org/10.1601/nm.3291)* Typhimurium LT2 reference genome (AE006468.1) using BWA MEM v0.7.13 \[[@R32]\]. Variant positions identified by GATK v2.6.5 UnifiedGenotyper \[[@R33]\] that passed the parameters \>90 % consensus, minimum read depth of 10, mapping quality (MQ) \>30, were imported into SnapperDB v0.2.5 \[[@R34]\]. Hierarchical single linkage clustering was performed on the pairwise SNP difference between all isolates at various distance thresholds (250, 100, 50, 25, 10, 5, 0). The result of the clustering is a SNP profile, or SNP address, that can be used to describe population structure based on clonal groups. Maximum-likelihood phylogenies were constructed based on the single-nucleotide polymorphism (SNP) using RaxML v8.2.8 \[[@R35]\].

Nanopore sequencing {#s4-7}
-------------------

Six isolates that failed to align to a previously described *mcr*-positive reference plasmid were selected for Oxford Nanopore Technologies MinION sequencing. DNA purification was performed using the Wizard Genomic DNA purification kit (Promega, Madison, WI, USA) for Gram-negative bacteria with minor modifications (double incubation and centrifugation times, substitution of vortex steps with manual inversions and elution in 100 µl of nuclease-free water). The DNA library was prepared using the Native Barcoding kit 1D, EXP-NBD103, and Ligation Sequencing kit 1D, SQK-LSK108, according to Oxford Nanopore Technologies' protocol, and sequenced using a FLO MINI106 flow cell. Raw FAST5 reads were basecalled using Albacore v2.0.1, with the flags '-f FLO-MIN106', '-k SQK-LSK108' and '\--barcoding' added. The reads were then subsequently converted to fasta and fastq using Poretools v0.6.0 \[[@R36]\]. Unicycler v0.4.2 \[[@R37]\] was used to assemble the reads using the flags '\--min_fasta_length 50' and '\--mode normal', and the hybrid option '−1 path/to/paired_end1 −2 path/to/paired_end2 -l path/to/long_reads' that combines Nanopore's long reads and Illumina's short reads. fastq files have been uploaded to NCBI BioProject -- PRJNA248792.

Results {#s5}
=======

Prevalence {#s5-1}
----------

Of the 33 205 *[Salmonella](http://doi.org/10.1601/nm.3291)* isolates screened for *mcr* variants, 52 genomes were positive for an *mcr* determinant. *mcr-1* was detected in 32 isolates, *mcr-3* was detected in 19 isolates and *mcr-5* was detected in a single isolate. Of the *mcr-1*-positive isolates, 19/32 were identified as *[S. enterica](http://doi.org/10.1601/nm.11017)* serovar Typhimurium, of which 13 were eBG1 (ST34 *n*=12, ST19 *n*=1) and 6 were eBG138 (all ST36). All *S*. Typhimurium-positive genomes were isolated from stool samples. The remaining *mcr-1*-positive isolates were identified as *[S. enterica](http://doi.org/10.1601/nm.11017)* serovars Stanley (*n*=3), Rissen (*n*=2) and Java (*n*=2), as well as single isolates of *[S. enterica](http://doi.org/10.1601/nm.11017)* serovars 4,\[5\],12:b:-, Thompson, Newport, Enteritidis, Agona and Virchow. One of the *[S. enterica](http://doi.org/10.1601/nm.11017)* serovar Java isolates was obtained from a poultry meat sample. The age distribution of *mcr-1*-positive cases was between 1 and 88 years old. Ten patients reported travel to Southeast Asia before the onset of symptoms, with Thailand (*n*=6) and Malaysia (*n*=2) being the countries visited most frequently, with single reports of travel to India, Borneo, Egypt, Spain and Poland. The highest number of *mcr-1*-positive isolates was received in 2017 (*n*=11), followed by 2016 (*n*=8), 2015 (*n*=8), 2014 (*n*=4) and 2012 (*n*=1).

Of the 19 *mcr-3*-positive isolates, 16 were *S*. Typhimurium, of which 13 were eBG1 (all ST34) and 3 were eBG138 (all ST36). Fifteen were from human faecal samples and one was from a food product. *mcr-3* was identified in a *Salmonella cholerae-suis* ST139 isolate from human blood. Single isolates of *Salmonella bovis-morbificans* and *[Salmonella](http://doi.org/10.1601/nm.3291)* Stanley were also positive for *mcr-3*. The age distribution of patients with *mcr-3*-positive samples was 3 to 68 years old, with eight patients having travelled to Thailand and single reports of travel to Vietnam, Malaysia and Cambodia. The greatest number of *mcr-3-*positive isolates was received in 2015 (*n*=9), followed by 2014 (*n*=6), 2016 (*n*=4) and 2017 (*n*=1).

The *mcr-5* gene was detected in an *S*. Typhimurium ST34 food isolate received in 2014. No isolates were positive for variants of *mcr-2*, *mcr-4*, *mcr-6*, *mcr-7* or *mcr-8*.

Plasmid types and *mcr* context mcr-1 {#s5-2}
-------------------------------------

The *mcr-1*-positive isolates contained one of four plasmid types that have been previously described, namely: pESTMCR (KU743383), pHNSHP45 (KP347127), pHNSHP45-2 (KU341381) and pH226B (KX129784). Thirteen shared a similar backbone to pESTMCR, an IncX4 plasmid (88--100 % identity) ([Fig. 1a](#F1){ref-type="fig"}); nine to pHNSHP45, an IncI2 plasmid (80--95 % identity) ([Fig. 1b](#F1){ref-type="fig"}); seven to pHNSHP45-2, an IncHI2 plasmid (70--90 % identity) ([Fig. 1c](#F1){ref-type="fig"}); while one isolate had a similar backbone to pH226B, an IncHI1 plasmid (80 % identity) ([Fig. 1d](#F1){ref-type="fig"}). Neither *S*. Rissen isolate (S37 and S38;obtained from second-degree relatives) aligned to any reference plasmid. Nanopore sequencing detected two copies of the *mcr-1* gene on the chromosome of isolate S37.

![Brig plots showing *mcr-1*-positive plasmids aligned to (a) pESTMCR, (b) pHNSHP45, c) pHNHSP45-2 and (d) pH226B. (e) The genetic context upstream and downstream of *mcr-*1.](mgen-6-331-g001){#F1}

Among the 32 *mcr-1*-positive isolates, 3 distinct genetic environments were observed immediately upstream and downstream of the *mcr-1* gene ([Fig. 1e](#F1){ref-type="fig"}). The IS*Apl1* element, thought to be involved in *mcr-1* mobilization, was found upstream of the *mcr-1* gene in two isolates with the IncI2 plasmid type, two isolates with an IncHI2 plasmid type and one isolate with the IncHI1 plasmid type, but was not present in all isolates with the IncX4 backbone. Both copies of chromosomally located *mcr-1* were located within a composite IS*Apl1* transposon designated as Tn*6330* \[[@R38]\]. All 32 isolates, including both chromosomally located *mcr-1* copies, had the *pap2* gene located downstream of *mcr-1*, with no flanking transposons near the *mcr-1* region when the IS*Apl1* element was absent. These three genetic environments have previously been observed in other studies \[[@R3]\].

mcr-3 {#s5-3}
-----

Seven isolates were found to harbour the *mcr-3* gene on an IncHI2 plasmid with a similar backbone (95--95 % identity) to pWJ1 (KY924928) ([Fig. 2a](#F2){ref-type="fig"}). The remaining 12 *mcr-3*-positive isolates did not align to a reference plasmid and a range of replicon types were detected by PlasmidFinder. To characterize the putative novel plasmids, a hybrid long-read/short-read sequencing strategy was deployed and three novel plasmids were described. Nanopore sequencing of *S*. Typhimurium isolates S46 and S48 revealed the presence of a novel 138 kb *mcr-3* plasmid belonging to IncA/C2 that was shared amongst eight isolates ([Fig. 2b](#F2){ref-type="fig"}). The *S*. Typhimurium isolate S54 was found to harbour a novel 113 kb plasmid containing the *mcr*-3 gene along with both IncFII and IncFIB replicons ([Fig. 2c](#F2){ref-type="fig"}). Finally, isolate S62 (*S*. Stanley) was found to harbour the *mcr-3* gene on a novel IncHI2A/IncY plasmid that was 236 kb in length ([Fig. 2d](#F2){ref-type="fig"}) with a separate copy of the *mcr-3* gene detected in the chromosome. *mcr-3* genes were also detected in the chromosome of the *S*. Typhimurium ST34 isolate S58 and in S61, an *S*. *bovis-morbificans* (ST1499) isolate.

![Brig plots showing *mcr-3*-positive plasmids aligned to (a) pWJ1, (b) the novel IncA/C2 plasmid, (c) the novel IncFII/IncFIB plasmid and (d) the novel IncHI2A/IncY plasmid. (e) The genetic context upstream and downstream of *mcr-*3.](mgen-6-331-g002){#F2}

The genetic context of *mcr-3* in these 19 isolates, including the chromosome-mediated *mcr-3* positive sequences, had a diacylglycerol kinase (*dgkA*) gene downstream of *mcr-3* flanked by a truncated (∆) IS*Kpn40* (41 bp) and an intact IS*Kpn40* ([Fig. 2e](#F2){ref-type="fig"}). All except the chromosomal *mcr-3* gene of S62 had a ∆Tn*As2* element found upstream of the ∆IS*Kpn40-mcr-3-dgkA-*IS*Kpn40* structure. Overall, four genetic environments were observed. Isolates with the IncHI2 pWJ1 backbone had an intact IS*26* and IS*15DI* located upstream and downstream of the ∆Tn*As2*-∆IS*Kpn40-mcr-3-dgkA-*IS*Kpn40* fragment, respectively. Isolates with the novel IncA/C2 and IncHI2A/IncY plasmid type had two complete IS*15DI* elements enclosing the fragment. Chromosome-mediated *mcr-3*-positive isolates and the single isolate with the novel IncFII/IncFIB plasmid type only had a ∆IS*26* located upstream of the fragment, while the chromosomal *mcr-3* sequence of S62 had a conserved ∆IS*Kpn40-mcr-3-dgkA-*IS*Kpn40* structure with no flanking IS or transposons. IS*Kpn40*, Tn*As2*, IS*26* and IS*15DI* have been identified in previous papers as key elements in the transposition of the *mcr-3* gene \[[@R13]\].

mcr-5 {#s5-4}
-----

The *mcr-5*-positive isolate identified in this study did not align to the previous *mcr-5* ColE plasmids pSE13-SA01718 (KY807921), pEC2380 (MG587004), pEC1066 (MG587003), pEC0674 (MF684783) and pI064-2 (MG800820), and instead was found on a small novel 10 kb plasmid with an uncategorized plasmid replication protein ([Fig. 3](#F3){ref-type="fig"}). This plasmid harboured the same *mcr-5* Tn*3* family transposon, Tn*6452,* described in pSE13-SA01718, pEC2380 and pEC1066 \[[@R5]\].

![(a) Brig plot showing the *mcr-5*-positive plasmid aligned to previously described *mcr-5* plasmids. (b) Brig plot showing novel *mcr-5* plasmid aligned to a related IncX1 plasmid.](mgen-6-331-g003){#F3}

Co-resistance to other antimicrobials {#s5-5}
-------------------------------------

Of the *mcr*-positive *[Salmonella](http://doi.org/10.1601/nm.3291)* isolates, all but four were defined as multidrug-resistant (MDR), with genotypically inferred resistance to at least three classes of antibiotics. Forty-seven isolates possessed β-lactamases, of which 10 encoded for extended-spectrum beta-lactamase (ESBL) production. Forty isolates were positive for *bla* ~TEM-1~ and six isolates had an alternative TEM variant. Three isolates were positive for *bla* ~CMY-2~, whilst none of the isolates possessed carbapenemase genes. The ESBL *bla* ~CTX-M-55~ was found in nine isolates and one isolate contained *bla* ~CTX-M-14~. The ESBL genotype was restricted to *mcr-3 Salmonella* samples. Forty-seven isolates harboured genes conferring resistance to a range of aminoglycosides. *dfrA*-mediated trimethoprim resistance determinants were detected in 24 isolates, with *dfrA12* being the most common gene (*n*=16). Forty-seven isolates contained tetracycline resistance determinants \[*tet*(A), *tet*(M) or *tet*(X)\], while 34 isolates contained *catA*, *floR* or *cmlA1* conferring resistance to chloramphenicol and/or florfenicol. Predicted reduced susceptibility to fluoroquinolones was largely mediated by *qnr* genes (*n*=24), with only five isolates displaying *gyrA* mutations in the quinolone resistance-determining region. Nine isolates displayed macrolide resistance determinants, with six isolates containing *mph*(A) in isolation or in conjunction with an *erm* gene. All genotypic profiles are described in Table S1 (available in the online version of this article).

Co-location of resistance determinants within the *mcr*-harbouring plasmids was also explored. *mcr-1*-positive isolates with an IncHI2-like backbone had additional resistance genes located on the same plasmid conferring resistance to aminoglycosides, tetracyclines and phenicols ([Fig. 1c](#F1){ref-type="fig"}). All *mcr-3*-positive isolates with the IncHI2 plasmid, pWJ1, also co-harboured resistance genes, including four that acquired *floR*, five that acquired *tet*(A) and *aph \[6\]-Id*, two with *mph*(A) and one with *qnrS1* and *bla* ~CTX-M-55~. Of the novel *mcr-3* plasmids, the IncA/C2 plasmid co-harboured *bla* ~CTX-M-55~ in 5/8 isolates and the *erm* gene in a single isolate, while all contained the resistance genes *floR*, *tet*(A), *aph \[6\]-Id* and *sul2*. The IncFII/IncFIB plasmid encoded *bla* ~CTX-M-55~ and *qnrS1* in conjunction with *mcr-3*, and the IncHI2A plasmid encoded *bla* ~TEM-1~ and a tetracycline resistance operon. The small *mcr-5* plasmid did not harbour any other resistance genes.

Phylogenetic analysis {#s5-6}
---------------------

The majority (36/52) of the *mcr*-positive samples were *S*. Typhimurium, with 27 of these isolates belonging to clonal complex eBG1. Placing the *mcr*-positive isolates into a phylogeny of 288 diverse *S*. Typhimurium genomes (100 SNP representatives) revealed that 26/27 clustered within the monophasic variant 4,\[5\],12:i- ST34 clade ([Fig. 4](#F4){ref-type="fig"}). One *mcr*-positive isolate (MLST 19) clustered adjacent to the ST34 monophasic clade, as defined by BAPS. Comparing the ST34 *mcr*-positive isolates against 1284 deduplicated (5 SNP representatives) ST34 genomes from routine surveillance of human clinical cases in England revealed that neither the *mcr-1*-positive isolates nor the *mcr-3*-positive isolates form a monophyletic group ([Fig. 5](#F5){ref-type="fig"}). Overlaying patient travel information onto the phylogeny revealed several broad clusters where reported travel to Southeast Asia predominated. Of the *mcr*-positive ST34 EBG1 isolates, 16/26 cluster in clades where most background isolates are from patients reporting travel to Asia, including 7/16 cases that did not report any travel information. The remaining 10 *mcr*-positive EBG1 isolates are found in a diverse set of clusters that tend to be more associated with travel to Europe.

![Maximum-likelihood SNP phylogeny of the 28 *mcr*-positive *[Salmonella](http://doi.org/10.1601/nm.3291)* Typhimurium eBG1 isolates against a background of 288 100-SNP representatives encompassing the diversity of the PHE *[Salmonella](http://doi.org/10.1601/nm.3291)* Typhimurium collection. Taxa are labelled and coloured by MLST and predominant phage types are labelled.](mgen-6-331-g004){#F4}

![Maximum-likelihood SNP phylogeny of the 28 *mcr*-positive *[Salmonella](http://doi.org/10.1601/nm.3291)* Typhimurium eBG1 isolates against a background of 1284 5-SNP representatives encompassing the diversity of the PHE *[Salmonella](http://doi.org/10.1601/nm.3291)* Typhimurium ST34 collection. Taxa are labelled by *mcr* gene and plasmid type and coloured by reported travel to either Europe (Blue) or Asia (Red).](mgen-6-331-g005){#F5}

Several *mcr* plasmids were restricted to Asian-associated clades. The *mcr-3* IncHI2 plasmid PJW1 was exclusively found in multiple Asian-associated clades of EBG1 but was also found in EBG36 associated with cases who had reported travel to Asia. The novel *mcr-3* IncA/C2 plasmid was also restricted to the Asian-associated clades and furthermore associated with *bla* ~CTX-M-55~. In contrast, the IncX4 *mcr-1* plasmid pESTMCR was more commonly associated with EBG1 isolates that cluster with patients reporting travel within Europe, as was the IncHI2 plasmid pHNHSHP4 5--2.

Discussion {#s6}
==========

All *mcr-*positive *[S. enterica](http://doi.org/10.1601/nm.11017)* serovars isolated in this study are established zoonotic pathogens with serovars Typhimurium, Stanley, Rissen and *cholerae-suis* commonly isolated in pigs \[[@R43]\]. This is consistent with the premise that the rise in colistin resistance in *[S. enterica](http://doi.org/10.1601/nm.11017)* has been driven by the selective pressure from colistin usage in agricultural animals rather than therapeutic use in humans \[[@R45]\]. Twenty-one patients that harboured *mcr*-positive strains reported travel to Southeast Asian countries, generally Thailand, where traditionally there are no veterinary antibiotic restrictions and antibiotics are readily available \[[@R46]\]. Furthermore, co-location of *tet*(A), *tet*(B)*, tet*(M), *catA, floR* or *cmlA1* on *mcr*-harbouring plasmids as a result of tetracycline and/or florfenicol use in food-producing animals could have also contributed to the selection of colistin resistance in *[Salmonella](http://doi.org/10.1601/nm.3291)* strains. Since the emergence of *mcr* genes, the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have implemented guidelines for the restricted use of colistin in veterinary medicine in Europe and Thailand. However, plasmids harbouring *mcr* genes appear to be well established in bacterial species belonging to *[Enterobacteriaceae](http://doi.org/10.1601/nm.3091)* and it is likely that the number of *mcr*-positive isolates and the identification of other *mcr* variants and *mcr-*harbouring plasmids will continue to increase.

The predominant plasmid types harbouring *mcr-1* in this routine surveillance study were IncX4 (*n*=13), IncI2 (*n*=9) and IncHI2 (*n*=7), which were the common plasmid types identified in other studies involving human and food *[S. enterica](http://doi.org/10.1601/nm.11017)* and *[E. coli](http://doi.org/10.1601/nm.3093)* isolates from Asia, Europe, the Americas and Africa \[[@R12]\]. For *mcr-3*-positive samples, 8/19 had a novel IncA/C2 replicon type with the second most common (7/19) being an IncHI2 plasmid backbone previously described in Danish travellers returning from Asia \[[@R49]\]. Two other novel *mcr-3*-containing plasmids were described in our data set, with one isolate harbouring an IncFII/FIB plasmid and another an IncHI2A/Y plasmid.

The *mcr-1-pap2* and *mcr-3-dgkA* gene cassette was shared by all *mcr-1* and *mcr-3*-positive isolates, respectively. Snesrud *et al.* demonstrated that mobilization of the *mcr-1* cassette involves a composite transposon of IS*Apl1* \[[@R51]\]. The loss of a single copy of IS*Apl1*, as seen in isolates with pHNSHP45-2, pHNSHP45 and pH226B backbones, or both copies of IS*Apl1*, as seen in isolates with an pESTMCR backbone, is a result of its 'copy out--paste in' mechanism, which prevents the transposition of the *mcr-1* cassette and transfixes it in the plasmid \[[@R51]\]. However, *mcr-1* cassettes with a single-ended IS*apl1* could still transpose if they maintained the inverted right repeat sequence of IS*apl1* immediately after the *pap2* gene \[[@R51]\]. Meanwhile, conjugation experiments have determined two circular forms that could have facilitated the dissemination of the *mcr-3* gene. One circular form, *mcr-3-dgkA*-IS*Kpn40*, was a 3535 bp derivative of the IS*Kpn40-mcr-3-dgkA*-IS*Kpn40* fragment \[[@R41]\]. The second circular intermediate was ∆IS*26*-Tn*As2*-∆IS*Kpn40-mcr-3-dgkA-*IS*Kpn40*, 5990 bp in size, mediating *mcr-3* transposition via homologous recombination between IS*26* and IS*15DI* components \[[@R13]\].

These genetic combinations were also observed in the chromosomal integration of the *mcr-1* and the *mcr-3* gene cassettes, which adds a new perspective to their transmissible nature. *mcr* genes can therefore co-occur with other chromosome- and plasmid-located resistance genes and transpose themselves from plasmid-to-plasmid, from plasmid-to-chromosome, and vice versa. This transmissibility is of great concern in the clinical setting with respect to the treatment of invasive pathogens such as *S*. *cholerae-suis*. *In silico* analysis determined that *mcr-3*-positive isolates had more resistance genes co-located on the same *mcr* plasmid compared to *mcr-1*-positive isolates, and that the IncHI2 plasmid type harboured more resistance genes compared to other plasmid types. A study by Ruichao Li *et al*. hypothesized that IncHI2 plasmid types could be the most efficient vessels for the dissemination of co-located *mcr* genes due to their diverse MDR region, which incorporates several transposons, IS and resistance genes, supplying multiple insertion sites for *mcr-1* \[[@R38]\].

Phylogenetic analysis of the most commonly detected *mcr-*positive serovar Typhimurium confirms previous reports of *mcr-*positive *[S. enterica](http://doi.org/10.1601/nm.11017)* circulating in Southeast Asia. The tree topology suggests multiple acquisitions of a restricted range of both *mcr-1*- and *mcr-3*-encoding plasmids within Asia and that those plasmids are more likely to encode additional antimicrobial resistance determinants, including ESBLs. These plasmids were also associated with other serovars of *[Salmonella](http://doi.org/10.1601/nm.3291)* associated with patients who reported travel to Asia. These data suggest that within Europe there appear to be alternative *mcr*-harbouring plasmids circulating that in general encode fewer additional antimicrobial resistance determinants.

This study demonstrates that routine WGS for public health surveillance can provide an effective screen for antimicrobial resistance determinants, including *mcr* genes. In addition, complementary long-read technologies can elucidate the genomic context of these determinants, offering insights into plasmid dissemination and linkage to other resistance genes. Finally, the phylogenetic context offers a perspective on the likely geographical origin of infection and plasmid transmission dynamics.
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